Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs
Domestic Animal Endocrinology · 2026
DOI: 10.1016/j.domaniend.2025.106979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Domestic Animal Endocrinology, 2026. Verfasst von Jean Vitor Bondavalli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pós-gradução em Produção e Sanidade Animal, Instituto Federal Catarinense - IFC, Araquari, Santa Catarina, Brazil; Pamplona Alimentos S.A, Rio do Sul…. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Vaccines, Contraceptive, Immunogenicity, Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
This study assessed the contraceptive effects of two vaccines formulated with recombinant gonadotropin-releasing hormone antigen (rGnRH antigen) conjugated with the heat-labile enterotoxin B subunit (LTB) protein from Escherichia coli in male pigs. Thirty-two piglets were assigned to four groups: Surg, surgically castrated at 3 days old; Vvx, non-castrated and vaccinated with a commercial vaccine (Vivax®) at 101 and 135 days old; rGnRH-400 and rGnRH-300, non-castrated and vaccinated at 101 and 135 days old with recombinant vaccines containing 400 µg or 300 µg rGnRH/LTB per dose, respectively. Growth performance was not affected by treatment (p ≥ 0.25). At 155 and 165 days old, piglets in the rGnRH-400 and rGnRH-300 groups exhibited anti-GnRH/LTB antibody levels were similar to those in the Vvx group (p > 0.05) or higher (p < 0.05) than those in the Vvx group. However, rGnRH-400 and rGnRH-300 piglets showed higher testosterone concentrations at 155 and 165 days old and greater testicular volumes at 165 days old than Vvx piglets (p < 0.05). Severe testicular lesions (scores 3 and 4) were more frequent in the Vvx group, while those in the rGnRH-400 group were mainly scored as 3, and only mild lesions (scores 1 and 2) were observed in the rGnRH-300 group. Overall, both recombinant vaccines elicited strong anti-GnRH/LTB antibody levels; however, they did not produce the same degree of testicular alterations or testosterone reduction as the commercial vaccine. Further studies are warranted to evaluate the contraceptive potential of these recombinant formulations, particularly the 400 µg rGnRH/LTB vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pós-gradução em Produção e Sanidade Animal, Instituto Federal Catarinense - IFC, Araquari, Santa Catarina, Brazil; Pamplona Alimentos S.A, Rio do Sul, Santa Catarina, Brazil.
- Pós-gradução em Produção e Sanidade Animal, Instituto Federal Catarinense - IFC, Araquari, Santa Catarina, Brazil; Instituto Federal Catarinense - IFC, Araquari, Santa Catarina, Brazil.
- Laboratório de Microbiologia, Programa de Pós Graduação em Biotecnologia, Centro de Desenvolvimento Tecnológico (CDTec), Universidade Federal de Pelotas - UFPel, Capão do Leão, Rio Grande do Sul, Brazil.
- Pamplona Alimentos S.A, Rio do Sul, Santa Catarina, Brazil.
- FiBRA, Faculdade de Veterinária, Universidade Federal de Pelotas - UFPel, Capão do Leão, Rio Grande do Sul, Brazil.
- Pós-gradução em Produção e Sanidade Animal, Instituto Federal Catarinense - IFC, Araquari, Santa Catarina, Brazil; Instituto Federal Catarinense - IFC, Araquari, Santa Catarina, Brazil. Electronic address: fabiana.morei…
Förderung
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Bondavalli, J. V., Quirino, M. W., Conrad, N., Peripolli, V., Schwegler, E., Silveira, M. F., Tutida, Y., Gasperin, B. G., Leite, F. P. L., Bianchi, I., & Moreira, F. (2026). Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs. Domestic Animal Endocrinology. https://doi.org/10.1016/j.domaniend.2025.106979
Vancouver
Bondavalli JV, Quirino MW, Conrad N, Peripolli V, Schwegler E, Silveira MF, et al. Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs. Domestic Animal Endocrinology. 2026. doi:10.1016/j.domaniend.2025.106979
BibTeX
@article{Bondavalli2026,
author = {Bondavalli, Jean Vitor and Quirino, Monike Willemin and Conrad, Neida and Peripolli, Vanessa and Schwegler, Elizabeth and Silveira, Matheus Folgearini and Tutida, Yuso and Gasperin, Bernardo Garziera and Leite, Fábio Pereira Leivas and Bianchi, Ivan and Moreira, Fabiana},
title = {Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs},
journal = {Domestic Animal Endocrinology},
year = {2026},
doi = {10.1016/j.domaniend.2025.106979}
}
EUVIMED